The Madison, Wisconsin-based firm, a subsidiary of Fujifilm, will supply iCell products to Roche for use in drug discovery.
SeouLin Bioscience will distribute the company's cell line products in the Republic of Korea, and provide first-level technical support for local customers.
The deal was completed on May 1, following the expiration of a tender offer in which Cellular Dynamics' shareholders tendered 90 percent of the company's common stock.
The deal marries Cellular Dynamics' human cell line manufacturing with Fujifilm's recombinant peptide cell scaffolding offerings.
NEW YORK (GenomeWeb) – Cellular Dynamics on Tuesday filed a shelf registration to offer up to $90 million in securities.
NEW YORK (GenomeWeb) – Cellular Dynamics reported after the close of the market on Monday that revenues in its first quarter were up 21 percent year over year, driven by collaborations and partnerships.
NEW YORK (GenomeWeb News) – Cellular Dynamics said after the close of the market on Monday that its revenues for the fourth quarter increased 45 percent year over year.
NEW YORK (GenomeWeb News) – Cellular Dynamics said after the close of the market on Tuesday that revenues in its third quarter more than doubled year over year.
NEW YORK (GenomeWeb News) – Cellular Dynamics International has priced its initial public offering at $12 per share, the stem cell technology firm announced late Wednesday.
NEW YORK (GenomeWeb News) – Cellular Dynamics International today priced its planned initial public offering, expected to bring in up to $51 million in net proceeds.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.